|
Vaccine
Therapy in Treating Patients With Malignant
Glioma
(Contact: Dr. Linda
M. Liau, UCLA, Los Angeles, CA, 90095)
Vaccine
Therapy in Treating Patients With Liver
Cancer
(Contact: Dr. Antoni
Ribas UCLA, Los Angeles, CA, 90095)
Chemotherapy
Followed By Vaccine Therapy in Treating
Patients With Extensive-Stage Small Cell
Lung Cancer (Contact:
Scott Antonia, H. Lee Moffitt Cancer Center
and Research Institute, Tampa, FL 33612)
Therapy
for Colorectal Cancer
(Contact:
NCI, Bethesda, MD 20892; E-mail: ncicssc@mail.nih.gov)
Study
of Tumor Antigen-Pulsed Autologous Dendritic
Cell Vaccination Administrated Subcutaneously
or Intranodally (Contact:
Mark A Mosby, U. of Arkansas for Medical
Sciences, Little Rock, Arkansas)
A
Safety and Feasibility Study of Active
Immunotherapy in Patients with Metastatic
Prostate Carcinoma Using Autologous Dendritic
Cells Pulsed with Antigen Encoded in Amplified
Autologous Tumor RNA
(Contact: Doris M.
Coleman, Duke University Medical Center,
Durham, North Carolina)
PROvenge
Trial
(Multiple sites throughout
the US) for early stage prostate cancer
patients who have undergone a radical
prostatectomy and whose only sign of disease
recurrence is a rise in serum PSA.
Tumor
Lysate Pulsed-Dendritic Cell Vaccines
after High-Dose Chemotherapy for Non-Hodgkin's
Lymphoma
Safety
and tolerability of a patient's own dendritic
cells combined with a new compound (KRN7000)
in patients with advanced cancer
(Principal Investigator:
Dr. Keren Osman, Rockerfeller University,
New York )
Evaluation
of the Effects of Local GM-CSF-in-adjuvant
Administration on Dendritic Cells in Skin
of Melanoma Patients and in Sentinel Lymph
Nodes
(Contact: Lori Elder,
U. of Virginia Medical School, Charlottesville,
VA)
A
Phase I/II Trial of Vaccination with Dendritophage
(Df) Pulsed with Multiple Peptides in
the Treatment of HLA-A2 Positive Patients
with Metastatic Colorectal Cancer (Contact: City of
Hope National Medical Center, 1500 East
Duarte Road, Duarte, CA 91010-3000)
A
Randomized, Double Blind, Placebo Controlled
Trial of Immunotherapy with Autologous
Antigen-Loaded Dendritic Cells For Asymptomatic
Metastatic Hormone Refractory Prostate
Cancer. (Contact: Nicole Zampardi,
Study Coordinator Staten Island Urological
Research, P.C. 1800 Clove Road, Staten
Island, NY)
Vaccine
Therapy With Either Neoadjuvant or Adjuvant
Chemotherapy and Adjuvant Radiation Therapy
in Treating Women With p53-Overexpressing
Stage II or Stage III Breast Cancer (Contact: Dr. Elizabeth
Reed, Eppley Cancer Center at the University
of Nebraska Medical Center, Omaha, Nebraska,
68198)
Vaccine
Therapy in Treating Patients With Advanced
or Metastatic Cancer expressing CEA (Contact: Herbert
Kim Lyerly Duke Comprehensive Cancer Center,
Durham, NC)
Vaccine
Therapy in Treating HLA-A201 Positive
Patients With Refractory CEA Expressing
Stage IV Cancer (Contact: Herbert Kim Lyerly Duke Comprehensive Cancer Center, Durham, NC)
Vaccine
Therapy in Treating Patients With Stage
III or Stage IV Melanoma
(contact: Gerold Schuler,
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum
Erlangen, Erlangen, D-91052, Germany)
|
